Efficacy and safety of trastuzumab deruxtecan among patients with HER2-expressing solid tumors: Biomarker and subgroup analyses from the cervical, endometrial, and ovarian cancer cohorts of the DESTINY-PanTumor02 study Meeting Abstract
| Authors: | Makker, V.; Oaknin, A.; Manso, L.; González-Martín, A.; Lugowska, I.; Meric-Bernstam, F.; Lorusso, D.; Banerjee, S.; Liao, J.; Siena, S.; Lu, C. H.; Prasongsook, N.; Melichar, B.; Fielding, A.; Jung, L.; Puvvada, S.; Michelini, F.; Lee, J. Y. |
| Abstract Title: | Efficacy and safety of trastuzumab deruxtecan among patients with HER2-expressing solid tumors: Biomarker and subgroup analyses from the cervical, endometrial, and ovarian cancer cohorts of the DESTINY-PanTumor02 study |
| Meeting Title: | Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer |
| Journal Title: | Gynecologic Oncology |
| Volume: | 190 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Mar 15-18 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-11-01 |
| Start Page: | S7 |
| End Page: | S8 |
| Language: | English |
| ACCESSION: | WOS:001330731400009 |
| DOI: | 10.1016/j.ygyno.2024.07.018 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 04 -- Source: Wos |
